National Stock Exchange of Australia

Alaska Mining Sells 51% Interest to Australian Nanotechnology Specialist

Retrieved on: 
Monday, August 15, 2022
NASB, Growth, Sale, Research, National Stock Exchange of Australia, Knowledge, Income, Mining, Company, Acquisition, Dato, National Stock Exchange, Rare-earth element, Sand

Nanopac principally engages in the research and development, manufacturing, distribution and servicing of nanotechnology materials and products.

Key Points: 
  • Nanopac principally engages in the research and development, manufacturing, distribution and servicing of nanotechnology materials and products.
  • Mr. Lee is the sole shareholder of Alaska Mining, which is an earthworks and mining specialist as well as a trader of a variety of goods and logistics services provider.
  • Under the agreement, the sale of the 51% interest in Alaska Mining by Mr. Lee to NASB will be satisfied through the issuance of new shares in Nanopac to be paid in two tranches.
  • As part of the share sale agreement, Mr. Lee will be appointed the managing director of Alaska Mining.

Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

Retrieved on: 
Wednesday, June 1, 2022
Company, Tax, BTG, National Stock Exchange of Australia, Marketing, NSX, OTCQX, OTC, European Authorized Representative, Forward-looking statement, Perception, Nature, CEO, CE, Failure, National Stock Exchange, Sale, GLOBE, Infection, Industry, Certification, Cancer, Terminology, Medical device

Since its launch in 2020, the Rapid Test Kit has been further optimized and upgraded with greatly improved performance indicators.

Key Points: 
  • Since its launch in 2020, the Rapid Test Kit has been further optimized and upgraded with greatly improved performance indicators.
  • The enhanced Rapid Test Kit is not only simple and convenient to use but also is further improved with faster detection time and higher level of accuracy.
  • We are pleased to receive the CE certification for our enhanced test kit as a recognition of the products quality and standard.
  • We are in the process of applying for regulatory approval for distribution of this test kit to other markets as well, said Jacky Zhang, CEO of Beroni Group.

TransPerfect Chosen by OliveX to Localize Zombies, Run! in Four Languages

Retrieved on: 
Monday, April 4, 2022
Electronic Design Automation, Search Engine Optimization, Search Engine Marketing, Other Professional Services, Data Management, Other Communications, Technology, Public Relations, Investor Relations, Marketing, Consulting, Advertising, Communications, Professional Services, Software, Internet, Exercise, NSX, National Stock Exchange of Australia, Translation, City, CEO, Language, 6, National Stock Exchange, Technology, Â, ISO, Solution, UI, Zombie, TransPerfect, OLIVEX, TRANSPERFECT

TransPerfects MediaNEXT division enabled OliveX to more quickly record each language by using the StudioNEXT cloud-based recording platform.

Key Points: 
  • TransPerfects MediaNEXT division enabled OliveX to more quickly record each language by using the StudioNEXT cloud-based recording platform.
  • To localize the app UI for Zombies, Run!, OliveX used Applanga, TransPerfects cloud-based translation management system specialized for mobile and web apps.
  • We are delighted with the work TransPerfect has done with Season 1, said Adrian Hon, CEO at Six to Start.
  • From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide.

TransPerfect Chosen by OliveX to Localize Zombies, Run! in Four Languages

Retrieved on: 
Monday, April 4, 2022
Exercise, NSX, National Stock Exchange of Australia, OLX, Multimedia, Translation, City, TransPerfect, CEO, Language, 6, National Stock Exchange, Technology, ISO, Solution, UI, Zombie, Film, Entertainment

NEW YORK and HONG KONG, April 4, 2022 /PRNewswire/ -- TransPerfect, the world's largest provider of language and technology solutions for global business, today announced that it has been selected by OliveX to support the international launch of its award-winning Zombies, Run! game. Services provided include casting and voice talents and app UI string localization into Spanish, Korean, French, and Japanese.

Key Points: 
  • TransPerfect's MediaNEXT division enabled OliveX to more quickly record each language by using the StudioNEXT cloud-based recording platform.
  • To localize the app UI for Zombies, Run!, OliveX used Applanga, TransPerfect's cloud-based translation management system specialized for mobile and web apps.
  • "We are delighted with the work TransPerfect has done with Season 1," said Adrian Hon, CEO at Six to Start.
  • From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide.

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

Retrieved on: 
Thursday, March 31, 2022
Company, NSX, Therapy, National Stock Exchange of Australia, University, BTG, Sale, Precigen, Pharmacy, Marketing, OTCQX, Forward-looking statement, Growth, Board, Research, Doctor of Philosophy, Perception, Cancer, CEO, Failure, GlaxoSmithKline, Industry, National Stock Exchange, Tax, LSE, GLOBE, Sustainability Accounting Standards Board, University of Nottingham, Consultant, Cephalon, Nature, Terminology, IPO, OTC, Acquisition, Patient, Infection, Medical device, Fine chemical, Polyomaviridae

Dr. Chiplin is an accomplished biotech executive and investor with a proven track record of building successful biotech companies.

Key Points: 
  • Dr. Chiplin is an accomplished biotech executive and investor with a proven track record of building successful biotech companies.
  • Dr. John Chiplin, PhD is Managing Director of Newstar Ventures Ltd. and Chairman of the Board of Biotherapy Services, N4 Pharma plc (LSE: N4P) and Scancell Holdings plc.
  • Dr. Chiplin has significant operational, investment and international experience in the life science and technology industries.
  • I am honored to join the Board at a pivotal time for the Company, said Dr. Chiplin.

Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Retrieved on: 
Wednesday, March 23, 2022
Charles M. Vest, Company, NSX, National Stock Exchange of Australia, BTG, Sale, Marketing, OTCQX, Forward-looking statement, Financial services, Biotechnology, Research, Perception, EDT, Conference, Q&A, Cancer, Failure, National Stock Exchange, Industry, Primary energy, Chief executive officer, Got Game Entertainment, Tax, GLOBE, Health information technology, Consultant, Nature, Terminology, OTC, Infection, Pharmaceutical industry, Health care

The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.

Key Points: 
  • The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.
  • This conference will be live on M-Vest.
  • Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases.
  • It is listed on the National Stock Exchange of Australia and traded on the OTC markets in the USA.

Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China

Retrieved on: 
Monday, January 31, 2022
Forward-looking statement, Infection, Sale, Neutralizing antibody, Failure, NSX, Consultant, Perception, Coronavirus diseases, Immunotherapy, Nature, US, Research, Transport, Laboratory, Cancer, Marketing, D, National Stock Exchange, GMP, Company, GLOBE, Tax, Zhuhai National Hi-Tech Industrial Development District, Phase, National Stock Exchange of Australia, Research and development, Industry, Terminology, OTC, BTG, OTCQX, DC, Fine chemical

The new R&D centre -- the first R&D site for Beroni -- will help the Company develop new drugs and medicines to cater for the vast needs of the Chinese market. To start with, the Company will occupy about 4,000 square metres (44,000 square feet) of office space for setting up the GMP plant and laboratories. Construction of the new R&D facilities is expected to be completed towards the end of the second quarter, and the entire R&D centre is expected to be ready in the second half of this year. Beroni intends to commit US$10 million to support the clinical trials in the new R&D facility. A new company, Beroni Pharmaceutical (Guangdong) Co., Ltd, has been established for this new venture with Beroni owning 80% of the entity’s shares and a local investor owning the other 20% shares. The Company will bring professional staff, scientists, technicians, and support teams together into a state-of-the-art hub for innovation and development of the company's future products and services.

Key Points: 
  • Beroni aspires to build a state-of-the-art facility with new preclinical research labs, manufacturing process development labs, and a GMP pilot manufacturing plant.
  • The new R&D centre -- the first R&D site for Beroni -- will help the Company develop new drugs and medicines to cater for the vast needs of the Chinese market.
  • To start with, the Company will occupy about 4,000 square metres (44,000 square feet) of office space for setting up the GMP plant and laboratories.
  • Beroni intends to commit US$10 million to support the clinical trials in the new R&D facility.

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

Retrieved on: 
Thursday, November 18, 2021
Trial of the century, Perception, CEO, Sale, School, Consultant, Industry, CE, Forward-looking statement, Company, Population, Cancer, BTG, COVID-19, Nature, OTCQX, Death, Research, Tax, GLOBE, National Stock Exchange of Australia, Marketing, Terminology, OTC, Infection, National Stock Exchange, NSX, Certification, Failure, Pharmaceutical industry, Vaccine

Beroni has so far produced and delivered about two thirds of the test kits to the buyer.

Key Points: 
  • Beroni has so far produced and delivered about two thirds of the test kits to the buyer.
  • The SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) optimizes the sample collection process.
  • This greatly improves the convenience of testing and the test results can be obtained within 10 minutes.
  • The antigen test kit was prepared using colloidal gold solid-phase immunochromatography and is used for qualitative assays of SARS-CoV-2 antigen samples in vitro.

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

Retrieved on: 
Thursday, October 28, 2021
Infection, OTCQX, Research, National Stock Exchange, Diagnosis, Neutralizing antibody, Cancer, Industry, Failure, The FEBS Journal, Perception, Capsid, Tax, Terminology, BTG, RNA, Severe acute respiratory syndrome coronavirus 2, Consultant, Nature, Forward-looking statement, Marketing, Company, CEO, OTC, National Stock Exchange of Australia, GLOBE, Sale, NSX, FEBS, Coronavirus, Pharmaceutical industry

The FEBS Journal is an international peer-reviewed non-profit society journal devoted to publishing high-quality papers reporting significant advances in the molecular life sciences.

Key Points: 
  • The FEBS Journal is an international peer-reviewed non-profit society journal devoted to publishing high-quality papers reporting significant advances in the molecular life sciences.
  • The published article is related to the scientific findings derived from Beronis current research of the development of a medical solution using single-domain antibodies (sdAbs) for the SARS-CoV-2 coronavirus.
  • Nucleocapsid protein is a major structural protein of SARS-CoV-2 and plays an important role in viral RNA packing, replication, assembly, and infection.
  • We are delighted to progress further in our coronavirus research program and to publish our new findings in the FEBS journal.

Sydney-based Morrison Securities turns to Eventus Systems for trade surveillance

Retrieved on: 
Thursday, May 13, 2021
Economy of New South Wales, Finance, National Stock Exchange of Australia, Security, Financial economics, Warrant, NSX, Money

b'AUSTIN, Texasand SYDNEY, May 13, 2021 /PRNewswire/ -- Eventus Systems, Inc. , a leading global provider of multi-asset class trade surveillance and market risk solutions, announced today that Sydney-based Morrison Securities , a major Australian stock brokerage firm, will deploy its Validus platform for trade surveillance in equities, equity options and warrants.

Key Points: 
  • b'AUSTIN, Texasand SYDNEY, May 13, 2021 /PRNewswire/ -- Eventus Systems, Inc. , a leading global provider of multi-asset class trade surveillance and market risk solutions, announced today that Sydney-based Morrison Securities , a major Australian stock brokerage firm, will deploy its Validus platform for trade surveillance in equities, equity options and warrants.
  • Increasingly, firms that have been using legacy surveillance platforms are turning to us for the efficiencies and flexibility that Validus provides.
  • "\nMorrison will go live on Validus in July for trade surveillance of the firm\'s activity on the ASX, Chi-X Australia (CXA) and the National Stock Exchange of Australia (NSX).
  • Morrison Securities clients can streamline their business operations and expand their service offerings, while benefiting from the experience and support of the firm\'s professional team.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/sydney-based-morrison-securities...\n'